Literature DB >> 18375533

Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review.

U Kalyoncu1, M Dougados, J-P Daurès, L Gossec.   

Abstract

OBJECTIVES: Patient-reported outcomes (PROs) have been increasingly recognised as important in rheumatoid arthritis (RA). The objective of this study was to assess the frequency of use of different PROs in recently published RA articles and to compare the tools used through a systemic literature review.
METHODS: (1) DATA SOURCE: In PUBMED MEDLINE database, articles reporting any type of clinical study for adult patients with RA, published between February 2005 and February 2007, and reporting any type of PRO. Articles were excluded if they did not concern adult RA or if they did not report any PROs. (2) DATA EXTRACTION: demographic characteristics of patients, study design, treatment assessed and all PROs. (3) DATA ANALYSIS: descriptive.
RESULTS: Of 109 reports, 50 (45%) were randomised controlled trials and 59 were other types of studies. A total of 63 questionnaires or tools for PROs were used, corresponding to 14 domains of health. Frequently reported domains (and most frequent tools) were: function, 83% (most frequent tool, health assessment questionnaire, HAQ); patient global assessment, 61% (most frequent tool, visual analogue scale, VAS); pain, 56% (VAS); and morning stiffness 27%. Domains such as fatigue, coping or sleep disturbance were infrequently reported.
CONCLUSIONS: PROs are reported with great heterogeneity in recently published trials in RA. Some domains that appear important from the patient's perspective are infrequently reported. Further work is needed in this field.

Entities:  

Mesh:

Year:  2008        PMID: 18375533     DOI: 10.1136/ard.2007.084848

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  58 in total

1.  Validity and responsiveness of the Michigan Hand Questionnaire in patients with rheumatoid arthritis: a multicenter, international study.

Authors:  Jennifer F Waljee; Kevin C Chung; H Myra Kim; Patricia B Burns; Frank D Burke; E F Shaw Wilgis; David A Fox
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06-02       Impact factor: 4.794

Review 2.  More than Just Minutes of Stiffness in the Morning: Report from the OMERACT Rheumatoid Arthritis Flare Group Stiffness Breakout Sessions.

Authors:  Ana-Maria Orbai; Serena Halls; Sarah Hewlett; Susan J Bartlett; Amye L Leong; Clifton O Bingham
Journal:  J Rheumatol       Date:  2015-03-01       Impact factor: 4.666

3.  Sensory and vascular changes in a rat monoarthritis model: prophylactic and therapeutic effects of meloxicam.

Authors:  Javeria Ali Hashmi; Kiran Yashpal; David W Holdsworth; James L Henry
Journal:  Inflamm Res       Date:  2010-03-28       Impact factor: 4.575

4.  Clinically important changes in short form 36 health survey scales for use in rheumatoid arthritis clinical trials: the impact of low responsiveness.

Authors:  Michael M Ward; Lori C Guthrie; Maria I Alba
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-12       Impact factor: 4.794

Review 5.  Core domain and outcome measurement sets for shoulder pain trials are needed: systematic review of physical therapy trials.

Authors:  Matthew J Page; Joanne E McKenzie; Sally E Green; Dorcas E Beaton; Nitin B Jain; Mario Lenza; Arianne P Verhagen; Stephen Surace; Jessica Deitch; Rachelle Buchbinder
Journal:  J Clin Epidemiol       Date:  2015-06-16       Impact factor: 6.437

6.  Potential of the HAQ score as clinical indicator suggesting comprehensive multidisciplinary assessments: the Swedish TIRA cohort 8 years after diagnosis of RA.

Authors:  Ingrid Thyberg; Ö Dahlström; M Björk; P Arvidsson; M Thyberg
Journal:  Clin Rheumatol       Date:  2012-01-17       Impact factor: 2.980

7.  Classical test theory and Rasch analysis validation of the Recent-Onset Arthritis Disability questionnaire in rheumatoid arthritis patients.

Authors:  Fausto Salaffi; Franco Franchignoni; Andrea Giordano; Alessandro Ciapetti; Stefania Gasparini; Marcella Ottonello
Journal:  Clin Rheumatol       Date:  2012-10-13       Impact factor: 2.980

8.  From the item to the outcome: the promising prospects of PROMIS.

Authors:  Daniel Aletaha
Journal:  Arthritis Res Ther       Date:  2010-02-01       Impact factor: 5.156

9.  Fatigue, pain and patient global assessment responses to biological treatment are unpredictable, and poorly inter-connected in individual rheumatoid arthritis patients followed in the daily clinic.

Authors:  Ole Rintek Madsen; Eva Marie Egsmose
Journal:  Rheumatol Int       Date:  2016-07-23       Impact factor: 2.631

Review 10.  Patient-reported outcomes in core domain sets for rheumatic diseases.

Authors:  Lilian H D van Tuyl; Maarten Boers
Journal:  Nat Rev Rheumatol       Date:  2015-09-01       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.